A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement
Original Article
G.D. Dangas, J.G. Tijssen, J. Wöhrle, L. Søndergaard, M. Gilard, H. Möllmann, R.R. Makkar, H.C. Herrmann, G. Giustino, S. Baldus, O.D. Backer, A.H. Guimarães, L. Gullestad, A. Kini, D.v. Lewinski, M. Mack, R. Moreno, U. Schäfer, J. Seeger, D. Tchétché, K. Thomitzek, M. Valgimigli, P. Vranckx, R.C. Welsh, P. Wildgoose, A.A. Volkl, A. Zazula, R.G.v. Amsterdam, R. Mehran, and S. Windecker
N Engl J Med 2020;382:120-129
Course summary
Available credit:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course opens:
01/08/2020
Course expires:
01/09/2022
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Sunday, January 9, 2022 - 11:59pm.

Facebook
X
LinkedIn
Forward